Iovance Biotherapeutics, Inc. (IOVA) by event type

IOVA moves most on analyst downgrades — a median of -2.04% at 30 minutes across 14 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the IOVA overview →

By event type

How IOVA reacts across 5 measured event types.

EventEventsMedian 30-min% positiveMedian to close
Analyst upgrades
619 of 2,717
14+0.29%50%+0.25%
Analyst downgrades
2,533 of 2,603
14-2.04%21%+3.74%
Rating reiterations
3,344 of 3,522
77-0.57%34%+0.43%
Price-target raises
810 of 1,790
12+0.02%50%-3.41%
Price-target cuts
1,493 of 1,527
22-0.78%36%-0.28%

Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 1 further class was observed with fewer than 10 measured events and is not published.

That’s how IOVA usually reacts — get an email when it moves on news →
Keep exploring

Every name measured for these event types: Analyst upgrades → · Analyst downgrades → · Rating reiterations → · Price-target raises → · Price-target cuts → · IOVA overview →

Other Healthcare names, measured the same way

TickerEventsMedian 30-min% positive
EXPRESS SCRIPTS (ESRX)1,137+0.02%51%
Neovasc Inc. - Common Shares (NVCN)1,136-0.47%37%
iRhythm Holdings, Inc. (IRTC)1,114-0.12%46%
GENOMIC HEALTH (GHDX)1,1110.00%49%

Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.